Our top pick for
Sangoma Technologies Corp is a software-infrastructure business based in the US. Sangoma Technologies shares (SANG) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$8.40|
|52-week range||$2.10 - $22.45|
|50-day moving average||$9.58|
|200-day moving average||$11.38|
|Wall St. target price||N/A|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.61|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-06-30)||8.4|
|1 month (2022-06-07)||-11.58%|
|3 months (2022-04-07)||-44.07%|
|6 months (2022-01-07)||-49.55%|
|1 year (2021-07-07)||213.43%|
|2 years (2020-07-07)||319.39%|
|3 years (2019-07-05)||611.86%|
|5 years (2017-07-06)||1,400.00%|
Valuing Sangoma Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sangoma Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Sangoma Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $10.3 million.
The EBITDA is a measure of a Sangoma Technologies's overall financial performance and is widely used to measure a its profitability.
To put Sangoma Technologies's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||$214.6 million|
|Gross profit TTM||$114 million|
|Return on assets TTM||-0.64%|
|Return on equity TTM||-3.31%|
|Market capitalisation||$172.4 million|
TTM: trailing 12 months
We're not expecting Sangoma Technologies to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Sangoma Technologies's shares have ranged in value from as little as $2.095 up to $22.4451. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sangoma Technologies's is 1.5736. This would suggest that Sangoma Technologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Sangoma Technologies's beta into context you can compare it against those of similar companies.
Sangoma Technologies Corporation develops, manufactures, distributes, and supports voice and data connectivity components for software-based communication applications worldwide. The company offers Switchvox, a business phone system; PBXact, a phone system; Internet protocol (IP) phones; service provider and voice over Internet protocol gateways; Switchvox Cloud, a unified communications solution; SIPstation SIP Trunking, a hosted session initiation protocol trunking service; PBXact Cloud, a cloud based private branch exchange service; Asterisk and FreePBX, an open source IP PBX software; and FAXStation, a fax-over-IP solution. It also provides session border controllers; telephony and media transcoding cards; and open source communications software. The company serves small and medium sized businesses, enterprises, original equipment manufacturers, carriers, and service providers. Sangoma Technologies Corporation was founded in 1984 and is headquartered in Markham, Canada. .
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.